Exome sequencing of tumor samples from S1107 “Randomized phase II evaluation of tivantinib and tivantinib in combination with erlotinib in patients with papillary renal cell carcinoma (pRCC)”
Year: 2017
Type: article
Source: Annals of Oncology
Authors: P. Twardowski, X. Wu, M. Plets, C. Tangen, E. Plimack, N. Agarwal, N.J. Vogelzang, J. Wang, S. Tao, I. Thomson, P. Lara
Institutions: City Of Hope National Medical Center, City of Hope, Fred Hutch Cancer Center, Fox Chase Cancer Center, Huntsman Cancer Institute, Comprehensive Cancer Centers of Nevada, The University of Texas at San Antonio Health Science Center, The University of Texas at San Antonio, UC Davis Comprehensive Cancer Center, University of California, Davis
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2761734563